GlassScriptPhysician profile
Margaret Andrin
NPI 1851345029
$860.54
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $32.30 · 2021: $33.09 · 2022: $213 · 2023: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $108.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $379.00 | 2019-2022 | |
| Exeltis, USA INC. | $70.05 | 2019-2023 | Nuvessa, Slynd |
| Daiichi Sankyo INC. | $60.68 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $60.16 | 2022-2023 | |
| Abbvie INC. | $58.16 | 2019-2022 | |
| Avion Pharmaceuticals | $56.89 | 2019-2022 | |
| Pfizer INC. | $33.83 | 2023 | |
| Alydia Health | $33.09 | 2021 | |
| Therapeuticsmd, INC. | $19.49 | 2019 | |
| Organon LLC | $18.28 | 2022 | |
| Evofem Biosciences, INC. | $14.99 | 2022 | |
| Agile Therapeutics, INC. | $14.27 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.23 | 2019 | |
| Merck Sharp & Dohme LLC | $13.82 | 2019 | |
| Allergan, INC. | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Andrin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.